Papillary Thyroid Cancer is cancer that forms in follicular cells in the thyroid and grows in small finger-like shapes. It grows slowly, is more common in women than in men, and often occurs before age 45. It is the most common type of thyroid cancer.
Nearly a million Americans live with thyroid cancer and doctors will diagnose more than 50,000 new cases this year. Fortunately, the survival rate for this kind of cancer is one of the best. Five years after diagnosis, more than 98 percent of patients are survivors.
New research recently published in the Journal of Pediatric Surgery found that post-operative success rates of pediatric thyroid patients, particularly children who require a thyroidectomy, correlate with the institution's patient volume.
Australian researchers have asked for changes in the way doctors tend to label low risk cancerous conditions as “cancer” leading to over treatment. Certain diagnoses such as localised prostate cancer or “stage 0” breast cancers need to be looked at say the researchers at the University of Sydney and Bond University to prevent aggressive treatment where it is not needed.
A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.
Thyroid cancer is a disease with good cure rates in most cases. In 5% of patients, however, the tumor becomes refractory to the available therapies and may spread all over the body, causing death.
There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease.
Most people diagnosed with cancer want to start treatment as soon as possible, for fear that delaying care will allow their tumor to grow out of control.
Penn State College of Medicine researchers have shown, for the first time, a possible correlation between the partial meltdown of the Three Mile Island Nuclear Generating Station and thyroid cancers in the counties surrounding the plant.
New study findings link traveling to an academic medical center for surgical removal of pancreatic or thyroid cancer with higher quality surgical care for both cancers, and longer survival for patients with pancreatic cancer compared with patients who receive treatment at a hospital closer to home.
Some flame retardants used in many home products appear to be associated with the most common type of thyroid cancer, papillary thyroid cancer (PTC), according to a new study being presented Saturday at the Endocrine Society's 99th annual meeting, ENDO 2017, in Orlando, Fla.
Charis Eng, M.D., Ph.D., of Cleveland Clinic and her team have discovered that a faulty, rarely studied gene called USF3 may predispose individuals to thyroid cancer. They recently published this discovery in Human Molecular Genetics.
A team of surgeons at Mount Sinai Beth Israel, led by William B. Inabnet III, MD, the Eugene W. Friedman, MD, Professor of Surgery and Chair for the Department of Surgery at MSBI and Chief of Endocrine Surgery Quality for the Mount Sinai Health System, have performed the first endoscopic transoral thyroidectomy in New York, and one of the first of its kind in the nation.
A new discovery from University of Alberta scientists represents an important milestone in the fight against thyroid cancer. In a study published in EBioMedicine and recently presented at the American Thyroid Association annual meeting, the team has identified a marker of aggressive disease for papillary thyroid cancer, which comprises about 90 per cent of all thyroid cancers.
The effect of radiation exposure related to the nuclear accidents that took place in Fukushima, Japan, and Chernobyl, Ukraine on thyroid cancer risk, whether dietary habits influence the risk of developing thyroid cancer, and recent study results with a triiodothyronine (T3) analog in an uncommon form of thyroid disease are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando, Florida.
The American Thyroid Association is pleased to announce that grants have been awarded to support projects proposed by leading young researchers. Three of these projects involve the genetic analysis of thyroid tumors carrying the BRAFV600E mutation, which is associated with the development of some forms of thyroid cancer and increased risk for distant metastases, more advanced disease, and higher mortality.
Researchers report that primary hyperparathyroidism in children and adolescents is usually caused by a sporadic single parathyroid adenoma.
There are two types of thyroid cells and therefore there are two broad types of thyroid cancer. Medullary carcinoma is derived from parafollicular or C cells, whereas follicular cells give rise to several types of thyroid cancers.
The prevalence of papillary thyroid carcinoma (PTC), the most common type of thyroid cancer, is increasing rapidly. New research to determine the impact of radioactive iodine (RAI) therapy on survival in PTC, describing a novel blood test able to detect circulating BRAFV600E-positive tumor DNA, and identifying a long non-coding RNA specifically associated with the thyroid that is down-regulated in PTC compared to normal thyroid tissue in patient-derived clinical specimens and cell cultures will be featured in oral presentations delivered at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.
Incidence of thyroid cancer is rising faster in Pennsylvania than in the rest of the United States as a whole, according to Penn State College of Medicine researchers.